15
Participants
Start Date
June 1, 2022
Primary Completion Date
March 30, 2023
Study Completion Date
March 30, 2023
Group I
First group are chronic periodontitis patients with diabetes mellitus type II who received scaling and root planning.
Group II
Second group will receive 250 mg of azithromycin per day for a period of 5 days, after an initial dose of 500 mg one hour before NSPT.
Group III
"Third group are Type 2 DM patients who received doxycycline 20mg twice/day.~Gingival crevicular fluid will be collected at 0, 1, and 3 months to assess Serum Resistin using a human Resistin enzyme-linked immunosorbent assay Kit following the manufacturer's protocol."
King Abdulaziz University, Jeddah
King Abdulaziz University
OTHER